CD44 and glioblastoma: Similarly, in TGFβ-treated glioblastoma U251MG cell cultures, the CD44 TM-ICD and CD44 ICD products were clearly detected in TGFβ-stimulated cultures after the inhibition of lysosomal or proteasomal degradation (Figure 1e).